Phys Clinical Cases · rheumatological
IgG4-Related Disease — DCE Clinical Case
DCE long-case clinical station: comprehensive management of a 62-year-old retired engineer who presents with six weeks of painless obstructive jaundice, three months of progressive painless submandibular gland enlargement and a rising creatinine from multi-organ IgG4-related disease (type 1 autoimmune pancreatitis, IgG4-related sclerosing cholangitis, Mikulicz syndrome, IgG4-related kidney disease and early retroperitoneal fibrosis) — the one-disease-many-organs concept, the clinicopathological diagnosis built on the histopathology triad, the correct use and limits of serum IgG4, the exclusion of pancreatobiliary malignancy and Sjogren syndrome, the 2019 ACR and EULAR classification criteria, the decompress-first principle for ureteric obstruction, and the integrated management plan of glucocorticoids and rituximab, with probing-question discussion and a short-case station on the salivary and lacrimal gland examination for Mikulicz syndrome.
On this page
Study tools
Target exams
IgG4-Related Disease — Clinical Case
References4ShowHide
- [1]Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease Lancet, 2015.PMID 25481618
- [2]Wallace ZS, Naden RP, Chari ST, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease Ann Rheum Dis, 2020.PMID 31796497
- [3]Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease Arthritis Rheumatol, 2015.PMID 25809420
- [4]Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial Ann Rheum Dis, 2015.PMID 25667206